Market Closed -
Other stock markets
|
After market 12:10:30 pm | |||
129.5 EUR | +1.49% | 129.5 | +0.02% |
Apr. 11 | Berenberg Reiterates UCB's Purchase Rating, Raises PT | MT |
Apr. 11 | UCB : Berenberg, Buy, raises its price target | CF |
Sales 2024 * | 5.62B 6.08B | Sales 2025 * | 6.33B 6.86B | Capitalization | 24.21B 26.21B |
---|---|---|---|---|---|
Net income 2024 * | 411M 445M | Net income 2025 * | 860M 931M | EV / Sales 2024 * | 4.6 x |
Net Debt 2024 * | 1.64B 1.78B | Net Debt 2025 * | 805M 871M | EV / Sales 2025 * | 3.95 x |
P/E ratio 2024 * |
60.9
x | P/E ratio 2025 * |
28.3
x | Employees | 8,767 |
Yield 2024 * |
1.1% | Yield 2025 * |
1.13% | Free-Float | 61.44% |
Latest transcript on UCB
1 day | +1.49% | ||
1 week | +6.58% | ||
Current month | +3.97% | ||
1 month | +6.37% | ||
3 months | +34.31% | ||
6 months | +87.14% | ||
Current year | +64.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 11-05-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 57 | 20-06-30 |
Chief Tech/Sci/R&D Officer | 63 | 17-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-04-27 | |
Dame Davies
BRD | Director/Board Member | 73 | 13-12-31 |
Chief Executive Officer | 65 | 11-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.88% | 2 M€ | +10.66% | ||
0.72% | 14 M€ | +5.66% | - | |
0.72% | 5 M€ | +10.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 129.5 | +1.49% | 257 310 |
24-05-22 | 127.6 | -0.62% | 332,622 |
24-05-21 | 128.4 | +1.34% | 359,445 |
24-05-20 | 126.7 | +1.60% | 159,685 |
24-05-17 | 124.7 | +2.63% | 282,474 |
Real-time Euronext Bruxelles, May 23, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.13% | 26.23B | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-15.06% | 32.79B | |
-21.89% | 14.52B | |
-7.58% | 13.09B | |
-42.60% | 11.6B | |
-12.64% | 11.5B | |
+4.94% | 8.82B | |
-13.45% | 7.92B |
- Stock Market
- Equities
- UCB Stock